Physician profile
Reena M Patel
NPI 1194108837
$17,404.45
in general payments reported to CMS, 2019-2025
73 companies · $2,100 in 2025
The $2,100 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $321 · 2021: $1,351 · 2022: $4,699 · 2023: $5,351 · 2024: $3,583 · 2025: $2,100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Consulting Fee: $610 · Education: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,216.80 |
| Consulting Fee | $610.00 |
| Education | $206.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $2,338.84 | 2020-2025 | Enhertu, Injectafer, Vanflyta |
| Exelixis INC. | $1,547.01 | 2021-2025 | Cabometyx |
| Novartis Pharmaceuticals Corporation | $1,427.88 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $829.23 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Regeneron Healthcare Solutions, INC. | $828.80 | 2021-2024 | Libtayo |
| Astrazeneca Pharmaceuticals LP | $765.06 | 2021-2025 | Lynparza, Calquence, Tagrisso |
| E.R. Squibb & Sons, L.L.C. | $674.29 | 2021-2025 | Opdivo, Opdualag |
| Pfizer INC. | $640.96 | 2022-2025 | |
| Seagen INC. | $603.14 | 2021-2023 | Padcev, Tukysa, Adcetris |
| Celgene Corporation | $509.73 | 2021-2025 | Pomalyst, Reblozyl, Opdualag |
| Genentech USA, INC. | $467.10 | 2022-2025 | Polivy, Tecentriq, Alecensa |
| Janssen Biotech, INC. | $436.57 | 2021-2025 | Erleada, Darzalex, Imbruvica |
| Glaxosmithkline, LLC. | $422.57 | 2021-2025 | Ojjaara, Jemperli, Zejula |
| Taiho Oncology, INC. | $378.43 | 2022-2025 | |
| Genzyme Corporation | $322.85 | 2021-2025 |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $267.33 | 2021-2025 | Monjuvi, Jakafi, Pemazyre |
| Lilly USA, LLC | $234.98 | 2021-2025 | Jaypirca, Verzenio, Retevmo |
| Amgen INC. | $225.64 | 2020-2023 | Kyprolis, Xgeva, Vectibix |
| Pharmacyclics LLC, An Abbvie Company | $216.36 | 2022-2023 | Imbruvica, Epkinly |
| Stemline Therapeutics INC. | $209.81 | 2023-2025 | Orserdu, Elzonris |
| Abbvie INC. | $203.32 | 2021-2025 | |
| Puma Biotechnology, INC. | $195.36 | 2021-2025 | |
| Aveo Pharmaceuticals, INC. | $178.45 | 2021-2024 | Fotivda |
| Bayer Healthcare Pharmaceuticals INC. | $174.99 | 2022-2025 | |
| G1 Therapeutics, INC. | $174.13 | 2022-2023 | Cosela |
| Takeda Pharmaceuticals U.S.A., INC. | $171.18 | 2022-2025 | Alunbrig, Iclusig, Fruzaqla |
| Eisai INC. | $168.64 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $159.99 | 2021-2023 | |
| Acrotech Biopharma INC. | $155.03 | 2021-2024 | Beleodaq |
| Kite Pharma, INC. | $152.33 | 2022-2025 | Yescarta |
| Array Biopharma INC | $143.83 | 2021-2025 | Lorbrena, Mektovi, Braftovi |
| Emd Serono, INC. | $141.58 | 2021-2025 | Tepmetko |
| Integra Lifesciences Corporation | $139.52 | 2021 | |
| Jazz Pharmaceuticals INC. | $135.06 | 2021-2025 | |
| Gilead Sciences, INC. | $114.63 | 2022-2025 | Trodelvy |
| Ipsen Biopharmaceuticals, INC | $101.02 | 2022-2025 | Onivyde |
| Beigene USA, INC. | $99.90 | 2022-2024 | Brukinsa, Tevimbra |
| Adaptive Biotechnologies Corporation | $94.90 | 2021-2023 | Clonoseq |
| Deciphera Pharmaceuticals INC. | $89.98 | 2022-2024 | Qinlock |
| Adc Therapeutics America, INC. | $69.29 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $67.58 | 2021-2024 | Ultomiris |
| Servier Pharmaceuticals LLC | $65.58 | 2022-2024 | |
| Karyopharm Therapeutics INC. | $64.57 | 2021-2024 | Xpovio |
| Astellas Pharma US INC | $64.23 | 2022 | |
| Sumitomo Pharma America, INC. | $62.37 | 2023-2025 | Orgovyx |
| Blueprint Medicines Corporation | $61.58 | 2022-2024 | Ayvakit |
| Azurity Pharmaceuticals, INC. | $60.15 | 2025 | Danziten |
| Tersera Therapeutics LLC | $59.89 | 2021-2025 | Quzyttir |
| Sobi, INC | $59.40 | 2022-2024 | |
| Rigel Pharmaceuticals, INC. | $51.61 | 2023-2024 | Rezlidhia, Tavalisse |
| Springworks Therapeutics, INC. | $47.42 | 2024-2025 | Ogsiveo |
| Geron Corporation | $47.31 | 2025 | Rytelo |
| Eusa Pharma (US) LLC | $45.85 | 2022 | |
| Genmab U.S., INC. | $36.40 | 2023-2024 | Epkinly |
| Foundation Medicine, INC. | $35.85 | 2023 | Foundationone Cdx |
| Amag Pharmaceuticals, INC. | $33.29 | 2021 | |
| Morphosys, US INC. | $33.20 | 2022-2024 | Monjuvi |
| Tempus Ai, INC | $27.98 | 2025 | Xt Cdx |
| Mirati Therapeutics, INC. | $27.65 | 2023-2024 | Krazati |
| Myovant Sciences INC. | $25.18 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.98 | 2022 | |
| Tg Therapeutics, INC. | $21.07 | 2022 | |
| Recordati_rare_diseases_inc. | $20.61 | 2025 | Sylvant |
| Menarini Silicon Biosystems, INC. | $19.64 | 2025 | |
| Amneal Pharmaceuticals LLC | $18.93 | 2024 | Avastin |
| Pharmacosmos Therapeutics INC. | $18.07 | 2024 | Cosela |
| Octapharma USA, INC. | $17.37 | 2024 | Octagam Immune Globulin (Human) |
| Organogenesis INC. | $15.93 | 2024 | Puraply Franchise |
| Secura Bio, INC. | $14.78 | 2022 | |
| Verity Pharmaceuticals INC. | $13.61 | 2025 | Trelstar |
| Organon LLC | $13.57 | 2024 | |
| Pharmaessentia USA Corporation | $12.64 | 2022 | |
| Aspira Women'S Health INC | $7.45 | 2024 | Ova1 |
Drugs and devices associated with these payments
Cabometyx $1,463Libtayo $744Keytruda $553Enhertu $386Scemblix $386Lynparza $367Kisqali $353Lonsurf $281Inqovi $281Tukysa $252Imbruvica $233Ibrance $194Padcev $168Calquence $167Opdivo $163Erleada $158Fabhalta $155Orserdu $152Opdualag $138Jaypirca $132Jevtana $130Polivy $125Piqray $124Fotivda $117Lorbrena $116Pomalyst $116Lenvima $115Tecentriq $115Verzenio $113Adcetris $112Avastin $111Reblozyl $111Mektovi $109Braftovi $109Tasigna $108Comirnaty $102Sarclisa $101Paxlovid $99.76Darzalex $99.63Tagrisso $99.38Ojjaara $96.64Elrexfio $96.55Injectafer $93.61Nubeqa $92.76Xofigo $92.76Rozlytrek $92.12Alecensa $92.12Retevmo $88.53Vanflyta $88.44Lunsumio $83.95Yescarta $82.32Beleodaq $82.09Jemperli $81.69Zejula $81.69Orgovyx $80.62Welireg $78.04Qinlock $74.19Xtandi $72.91Inlyta $71.73Bosulif $71.39Monjuvi $71.24Venclexta $70.50Benlysta $68.65Nerlynx $67.19Xalkori $66.91Zepzelca $66.59Tivdak $64.32Eliquis $62.30Onivyde $60.80Tecvayli $60.62Talvey $60.62Danziten $60.15Gavreto $59.10Elzonris $57.51Cosela $55.13Epkinly $54.82Tavalisse $51.61Rezlidhia $51.61Brukinsa $51.42Shingrix $50.46Datroway $48.36Ogsiveo $47.42Rytelo $47.31Vonjo $46.25Keytruda Qlex $46.11Columvi $43.18Emrelis $42.49Xpovio $42.34Gazyva $40.77Ayvakit $40.59Promacta $38.95Phesgo $38.73Jakafi $37.81Ultomiris $37.75Lutathera $37.54Talzenna $37.41Alunbrig $37.18Iclusig $34.69Tibsovo $34.05Pluvicto $30.56
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reena Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.